2023 Q4 Form 10-Q Financial Statement

#000085698223000058 Filed on October 26, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $324.5M $315.2M
YoY Change 10.6% 9.77%
Cost Of Revenue $174.0M $173.0M
YoY Change 9.52% 9.1%
Gross Profit $150.5M $142.2M
YoY Change 11.87% 10.6%
Gross Profit Margin 46.39% 45.11%
Selling, General & Admin $95.75M $86.85M
YoY Change 15.03% -3.26%
% of Gross Profit 63.61% 61.08%
Research & Development $21.64M $19.65M
YoY Change 5.89% 2.21%
% of Gross Profit 14.38% 13.82%
Depreciation & Amortization $23.63M $24.10M
YoY Change 15.29% 18.08%
% of Gross Profit 15.7% 16.95%
Operating Expenses $116.9M $107.1M
YoY Change 12.87% -2.6%
Operating Profit $33.61M $35.14M
YoY Change 8.55% 88.33%
Interest Expense -$3.054M $4.841M
YoY Change 50.0% 164.39%
% of Operating Profit -9.09% 13.78%
Other Income/Expense, Net $909.0K -$4.915M
YoY Change -48.76% 365.88%
Pretax Income $31.47M $30.22M
YoY Change 4.35% 71.7%
Income Tax $3.838M $4.388M
% Of Pretax Income 12.2% 14.52%
Net Earnings $27.63M $25.83M
YoY Change -17.28% 69.16%
Net Earnings / Revenue 8.51% 8.2%
Basic Earnings Per Share $0.45
Diluted Earnings Per Share $0.47 $0.44
COMMON SHARES
Basic Shares Outstanding 57.75M 57.64M
Diluted Shares Outstanding 58.38M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $587.0M $58.70M
YoY Change 905.06% 14.02%
Cash & Equivalents $587.0M $58.67M
Short-Term Investments
Other Short-Term Assets $28.30M $31.90M
YoY Change 7.87% 3.23%
Inventory $303.9M $303.9M
Prepaid Expenses
Receivables $177.9M $167.8M
Other Receivables $11.38M $23.00M
Total Short-Term Assets $1.108B $585.3M
YoY Change 109.51% 17.1%
LONG-TERM ASSETS
Property, Plant & Equipment $383.5M $383.3M
YoY Change 0.14% 1.91%
Goodwill $382.2M $381.1M
YoY Change 6.23% 6.42%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $54.79M $48.55M
YoY Change 23.54% 9.37%
Total Long-Term Assets $1.217B $1.223B
YoY Change 7.22% 7.97%
TOTAL ASSETS
Total Short-Term Assets $1.108B $585.3M
Total Long-Term Assets $1.217B $1.223B
Total Assets $2.325B $1.809B
YoY Change 39.74% 10.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $65.94M $48.90M
YoY Change -3.74% -22.63%
Accrued Expenses $120.4M $119.3M
YoY Change -2.23% -4.19%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $3.750M
YoY Change -66.67%
Total Short-Term Liabilities $203.6M $187.1M
YoY Change -7.74% -12.16%
LONG-TERM LIABILITIES
Long-Term Debt $823.0M $282.4M
YoY Change 340.68% 37.47%
Other Long-Term Liabilities $13.83M $13.81M
YoY Change -6.15% -16.29%
Total Long-Term Liabilities $836.8M $296.2M
YoY Change 315.32% 33.47%
TOTAL LIABILITIES
Total Short-Term Liabilities $203.6M $187.1M
Total Long-Term Liabilities $836.8M $296.2M
Total Liabilities $1.123B $578.6M
YoY Change 116.19% 6.38%
SHAREHOLDERS EQUITY
Retained Earnings $575.2M $547.6M
YoY Change 19.64% 22.39%
Common Stock $638.2M $695.2M
YoY Change -5.48% 5.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.202B $1.230B
YoY Change
Total Liabilities & Shareholders Equity $2.325B $1.809B
YoY Change 39.74% 10.77%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $27.63M $25.83M
YoY Change -17.28% 69.16%
Depreciation, Depletion And Amortization $23.63M $24.10M
YoY Change 15.29% 18.08%
Cash From Operating Activities $62.25M $51.10M
YoY Change 122.26% 43.99%
INVESTING ACTIVITIES
Capital Expenditures $7.794M $8.600M
YoY Change -37.6% -154.51%
Acquisitions
YoY Change
Other Investing Activities -$549.0K -$700.0K
YoY Change -88.65% -29.51%
Cash From Investing Activities -$8.343M -$9.200M
YoY Change -51.86% -45.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 472.8M -54.50M
YoY Change -8324.21% 101.35%
NET CHANGE
Cash From Operating Activities 62.25M 51.10M
Cash From Investing Activities -8.343M -9.200M
Cash From Financing Activities 472.8M -54.50M
Net Change In Cash 526.7M -12.60M
YoY Change 10583.94% 50.95%
FREE CASH FLOW
Cash From Operating Activities $62.25M $51.10M
Capital Expenditures $7.794M $8.600M
Free Cash Flow $54.46M $42.50M
YoY Change 250.93% -17.1%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents Current Asset Statement Of Financial Position Extensible List
RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssetsCurrent
dei Entity Central Index Key
EntityCentralIndexKey
0000856982
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Entity Registrant Name
EntityRegistrantName
MERIT MEDICAL SYSTEMS INC
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
57746000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
57306000
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents Current Asset Statement Of Financial Position Extensible List
RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssetsCurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-18592
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
UT
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0447695
dei Entity Address Address Line1
EntityAddressAddressLine1
1600 West Merit Parkway
dei Entity Address City Or Town
EntityAddressCityOrTown
South Jordan
dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84095
dei City Area Code
CityAreaCode
801
dei Local Phone Number
LocalPhoneNumber
253-1600
dei Security12b Title
Security12bTitle
Common Stock, no par value
dei Trading Symbol
TradingSymbol
MMSI
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
57750462
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
58673000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
58408000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
8721000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
8423000
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
167824000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
164677000
CY2023Q3 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
13576000
CY2022Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
12992000
CY2023Q3 us-gaap Inventory Net
InventoryNet
303923000
CY2022Q4 us-gaap Inventory Net
InventoryNet
265991000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
27954000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
22324000
CY2023Q3 us-gaap Prepaid Taxes
PrepaidTaxes
3936000
CY2022Q4 us-gaap Prepaid Taxes
PrepaidTaxes
3913000
CY2023Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
9432000
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
779000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
585318000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
529084000
CY2023Q3 us-gaap Land
Land
26017000
CY2022Q4 us-gaap Land
Land
25940000
CY2023Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
190825000
CY2022Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
189148000
CY2023Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
313600000
CY2022Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
299089000
CY2023Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
66451000
CY2022Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
61128000
CY2023Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
53208000
CY2022Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
49673000
CY2023Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
60492000
CY2022Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
61269000
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
710593000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
686247000
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
327267000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
303271000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
383326000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
382976000
CY2023Q3 us-gaap Goodwill
Goodwill
381052000
CY2022Q4 us-gaap Goodwill
Goodwill
359821000
CY2023Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
6438000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
6599000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
63633000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
65262000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
48545000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
44352000
CY2023Q3 mmsi Intangible Assets Net Goodwill And Other Assets Noncurrent
IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent
839861000
CY2022Q4 mmsi Intangible Assets Net Goodwill And Other Assets Noncurrent
IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent
751906000
CY2023Q3 us-gaap Assets
Assets
1808505000
CY2022Q4 us-gaap Assets
Assets
1663966000
CY2023Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
48862000
CY2022Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
68504000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
119291000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
123189000
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
3750000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
11250000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11688000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11005000
CY2023Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3542000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
6697000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
187133000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
220645000
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
282370000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
186759000
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
18458000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
18462000
CY2023Q3 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
347000
CY2022Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
347000
CY2023Q3 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
1912000
CY2022Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
1912000
CY2023Q3 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
15508000
CY2022Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
15264000
CY2023Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1631000
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1708000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
57455000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
59736000
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13806000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
14736000
CY2023Q3 us-gaap Liabilities
Liabilities
578620000
CY2022Q4 us-gaap Liabilities
Liabilities
519569000
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
57746000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
57306000
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
695181000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
675174000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
547555000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
480773000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-12851000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-11550000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1229885000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1144397000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1808505000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1663966000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
315230000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
287175000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
932851000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
857566000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
173031000
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
158602000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
499508000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
473019000
CY2023Q3 us-gaap Gross Profit
GrossProfit
142199000
CY2022Q3 us-gaap Gross Profit
GrossProfit
128573000
us-gaap Gross Profit
GrossProfit
433343000
us-gaap Gross Profit
GrossProfit
384547000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
86854000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
89780000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
277925000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
259282000
CY2023Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
19646000
CY2022Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
19221000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
61089000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
55074000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
270000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
1672000
CY2023Q3 mmsi Business Combination Contingent Consideration Arrangements Contingent Consideration Benefit
BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit
-562000
CY2022Q3 mmsi Business Combination Contingent Consideration Arrangements Contingent Consideration Benefit
BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit
-915000
mmsi Business Combination Contingent Consideration Arrangements Contingent Consideration Benefit
BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit
-2177000
mmsi Business Combination Contingent Consideration Arrangements Contingent Consideration Benefit
BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit
-4702000
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
1550000
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
6671000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
107062000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
109916000
us-gaap Operating Expenses
OperatingExpenses
343011000
us-gaap Operating Expenses
OperatingExpenses
327401000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
35137000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
18657000
us-gaap Operating Income Loss
OperatingIncomeLoss
90332000
us-gaap Operating Income Loss
OperatingIncomeLoss
57146000
CY2023Q3 us-gaap Investment Income Net
InvestmentIncomeNet
181000
CY2022Q3 us-gaap Investment Income Net
InvestmentIncomeNet
116000
us-gaap Investment Income Net
InvestmentIncomeNet
533000
us-gaap Investment Income Net
InvestmentIncomeNet
316000
CY2023Q3 us-gaap Interest Expense
InterestExpense
4841000
CY2022Q3 us-gaap Interest Expense
InterestExpense
1831000
us-gaap Interest Expense
InterestExpense
10534000
us-gaap Interest Expense
InterestExpense
4180000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-255000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
660000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
291000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-808000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4915000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1055000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9710000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4672000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
30222000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
17602000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
80622000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
52474000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4388000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2330000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13840000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11359000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
25834000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
15272000
us-gaap Net Income Loss
NetIncomeLoss
66782000
us-gaap Net Income Loss
NetIncomeLoss
41115000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.73
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.44
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.14
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.71
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57682000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56835000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57525000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56707000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58375000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57586000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58345000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57573000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
25834000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
15272000
us-gaap Net Income Loss
NetIncomeLoss
66782000
us-gaap Net Income Loss
NetIncomeLoss
41115000
CY2023Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
-539000
CY2022Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
3850000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
1192000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
13182000
CY2023Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
-129000
CY2022Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
942000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
286000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
3226000
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
-2914000
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
-9003000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
-2190000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
-18775000
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
-17000
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
-85000
us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
17000
us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
-81000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3307000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-6010000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1301000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-8738000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
22527000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
9262000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
65481000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
32377000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1144397000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
20703000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
621000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3498000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3726000
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
302000
CY2023Q1 mmsi Stock Surrendered During Period Value Payroll Tax Liabilities Stock Options Exercised
StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised
1592000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1171655000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
20245000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1385000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4980000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5154000
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
281000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1203700000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
25834000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3307000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5206000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7555000
CY2023Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
237000
CY2023Q3 mmsi Stock Surrendered During Period Value Payroll Tax Liabilities Stock Options Exercised
StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised
3531000
CY2023Q3 mmsi Stock Surrendered During Period Value Stock Options Exercised
StockSurrenderedDuringPeriodValueStockOptionsExercised
5809000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1229885000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1039799000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
10545000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1338000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4212000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1320000
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
320000
CY2022Q1 mmsi Stock Surrendered During Period Value Payroll Tax Liabilities Stock Options Exercised
StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised
1015000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1056519000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
15298000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4066000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3952000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1303000
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
301000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1073307000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
15272000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-6010000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3893000
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4141000
CY2022Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
246000
CY2022Q3 mmsi Stock Surrendered During Period Value Payroll Tax Liabilities Stock Options Exercised
StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised
1110000
CY2022Q3 mmsi Stock Surrendered During Period Value Stock Options Exercised
StockSurrenderedDuringPeriodValueStockOptionsExercised
898000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
1088841000
us-gaap Net Income Loss
NetIncomeLoss
66782000
us-gaap Net Income Loss
NetIncomeLoss
41115000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
66359000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
61312000
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-1389000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-4761000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-196000
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
461000
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
1733000
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
1550000
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
6671000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
8621000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
7819000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
2177000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
2888000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
78000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
81000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
744000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
453000
us-gaap Share Based Compensation
ShareBasedCompensation
15346000
us-gaap Share Based Compensation
ShareBasedCompensation
13691000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3852000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9063000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
1040000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-5669000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
34426000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
30735000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
72000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4186000
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
24000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
8682000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
1713000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
719000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1848000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-20332000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
9752000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-599000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-8861000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-3431000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1374000
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
245000
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-3325000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-8573000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-8406000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-2318000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-509000
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
16118000
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
45168000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
82900000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
86283000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
27151000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
32539000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1756000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1909000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
181000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
63000
us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
-971000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
138278000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
4712000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-167004000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-40068000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
11446000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6733000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
480499000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
172336000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
391624000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
198593000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
5240000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
3502000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
32862000
mmsi Payments Related To Tax Withholding For Exchange Of Common Stock
PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock
5123000
mmsi Payments Related To Tax Withholding For Exchange Of Common Stock
PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock
2125000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
86456000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-54511000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-2181000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-5862000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
171000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-14158000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60558000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
67750000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60729000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
53592000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
58673000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
51481000
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
2056000
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
2111000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60729000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
53592000
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
941000
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
565000
us-gaap Interest Paid Net
InterestPaidNet
9572000
us-gaap Interest Paid Net
InterestPaidNet
4087000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
24875000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
14013000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4613000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1899000
mmsi Acquisition Of Developed Technology In Accrued Expenses
AcquisitionOfDevelopedTechnologyInAccruedExpenses
3674000
mmsi Acquisition Of Developed Technology In Accrued Expenses
AcquisitionOfDevelopedTechnologyInAccruedExpenses
4526000
mmsi Stock Issued During Period Shares Treasury Stock Reissued Share Based Payment Arrangement
StockIssuedDuringPeriodSharesTreasuryStockReissuedShareBasedPaymentArrangement
86000
mmsi Stock Issued During Period Shares Treasury Stock Reissued Share Based Payment Arrangement
StockIssuedDuringPeriodSharesTreasuryStockReissuedShareBasedPaymentArrangement
15000
mmsi Stock Surrendered During Period Value Stock Options Exercised
StockSurrenderedDuringPeriodValueStockOptionsExercised
5809000
mmsi Stock Surrendered During Period Value Stock Options Exercised
StockSurrenderedDuringPeriodValueStockOptionsExercised
898000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
7560000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
8948000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
315230000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
287175000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
932851000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
857566000
CY2023Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
156074000
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
147051000
CY2023Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
34092000
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
29534000
CY2023Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
113757000
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
89406000
CY2023Q3 us-gaap Inventory Net
InventoryNet
303923000
CY2022Q4 us-gaap Inventory Net
InventoryNet
265991000
CY2022Q4 us-gaap Goodwill
Goodwill
359821000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-305000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
21536000
CY2023Q3 us-gaap Goodwill
Goodwill
381052000
CY2023Q3 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
8300000
CY2022Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
8300000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
15400000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
41100000
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
12100000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
36300000
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
15764000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
59656000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
57661000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
46955000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
43774000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4400000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2300000
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.145
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.132
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13800000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11400000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.172
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.216
CY2023Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
943000
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
179000
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
286120000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
198009000
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
3750000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
11250000
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
282370000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
186759000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
938000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
3750000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
5625000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
7500000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
9375000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
259875000
CY2023Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
287063000
CY2023Q3 us-gaap Interest Expense
InterestExpense
4841000
CY2022Q3 us-gaap Interest Expense
InterestExpense
1831000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
315230000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
287175000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
173031000
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
158602000
us-gaap Interest Expense
InterestExpense
10534000
us-gaap Interest Expense
InterestExpense
4180000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
932851000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
857566000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
499508000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
473019000
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.14
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.71
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1242000
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1641000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1091000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1612000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
25834000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
15272000
us-gaap Net Income Loss
NetIncomeLoss
66782000
us-gaap Net Income Loss
NetIncomeLoss
41115000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57682000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56835000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57525000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56707000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.73
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57682000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56835000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57525000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56707000
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
693000
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
751000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
820000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
866000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58375000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57586000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58345000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57573000
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.44
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5797000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4598000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15346000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13691000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
315230000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
287175000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
932851000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
857566000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
35137000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
18657000
us-gaap Operating Income Loss
OperatingIncomeLoss
90332000
us-gaap Operating Income Loss
OperatingIncomeLoss
57146000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4915000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1055000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9710000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4672000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4388000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2330000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13840000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11359000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
25834000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
15272000
us-gaap Net Income Loss
NetIncomeLoss
66782000
us-gaap Net Income Loss
NetIncomeLoss
41115000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
3500000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
32900000
us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
12700000
us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
1800000
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
296000
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
192000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
281000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
199000
CY2023Q3 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
32000
CY2022Q3 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-6000
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
47000
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-13000
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
328000
CY2022Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
186000
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
328000
CY2022Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
186000

Files In Submission

Name View Source Status
mmsi-20230930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
mmsi-20230930_def.xml Edgar Link unprocessable
0000856982-23-000058-index-headers.html Edgar Link pending
0000856982-23-000058-index.html Edgar Link pending
0000856982-23-000058.txt Edgar Link pending
0000856982-23-000058-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mmsi-20230930.xsd Edgar Link pending
mmsi-20230930x10q.htm Edgar Link pending
mmsi-20230930x10q001.jpg Edgar Link pending
mmsi-20230930xex31d1.htm Edgar Link pending
mmsi-20230930xex31d2.htm Edgar Link pending
mmsi-20230930xex32d1.htm Edgar Link pending
mmsi-20230930xex32d2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
mmsi-20230930_lab.xml Edgar Link unprocessable
mmsi-20230930_pre.xml Edgar Link unprocessable
mmsi-20230930x10q_htm.xml Edgar Link completed
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending